MnSOD Acetylation Promotes Cancer Stem Cell Phenotypes in Breast Cancer

MnSOD 乙酰化促进乳腺癌干细胞表型

基本信息

  • 批准号:
    9763487
  • 负责人:
  • 金额:
    $ 34.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-08-14 至 2020-07-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY / ABSTRACT: Cancer stem cells are a rare and yet critically important subpopulation of cells in tumors associated with treatment failure and metastatic recurrence. Though it is becoming increasingly clear that targeting this subpopulation could lead to therapies with better odds of a cure it is still unknown how these cells originate and what are the biochemical processes that promote “stemness” in cancer. Our laboratory found that alterations in the metabolism of mitochondrial reactive oxygen species (ROS) promote aberrant activation of hypoxia-induced factor 2α (HIF2α). The activation of HIF2α is a well-established mechanism of stemness that has also been implicated in metastatic recurrence as well as treatment failure in women with breast cancer. We found that a posttranslational modification (i.e. acetylation) of a primary enzyme involved in the metabolism of mitochondrial ROS, manganese superoxide dismutase (MnSOD) breaks the tetrameric structure that has antioxidant function turning the enzyme into a monomer that promotes ROS formation and activates HIF2α. We also found that MnSOD-K68Ac accumulates prominently in breast cancers expressing low estrogen receptor levels. Hence, it is proposed that MnSOD has a dichotomous behavior functioning as a suppressor of tumor initiation (antioxidant function) and yet promotes cancer stem cell reprogramming later on in established tumors. This proposition is supported by the finding of strong associations between a MnSOD/HIF2α signature present in metastatic lesions compared to primary tumor samples from the same breast cancer patients. Hence, this application aims at determining: (1) if MnSOD-Ac reprograms tumor cells to stem-like phenotypes associated with chemoresistance. (2) if the biochemical and/or genetic targeting of MnSOD-Ac or HIF2α in established tumors of mice with the MnSODhigh/HIF2α signature (MMTV.PyVT) suppresses chemoresistance and/or metastasis. (3) if there is an association between subsets of women with breast cancer that exhibit a MnSODhigh or MnSOD-Ac, or MnSOD-ROS-HIF2α molecular axis signature and develop chemoresistance or have increased risk of metastatic recurrence.
项目摘要/摘要:

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Marcelo G Bonini其他文献

245 - Human Mitochondrial SOD2 and Bacterial SOD A Incorporated with Iron Become Prooxidant Peroxidases
  • DOI:
    10.1016/j.freeradbiomed.2015.10.292
  • 发表时间:
    2015-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Douglas Ganini;Rnobert M. Petrovichb;Lori L Edwards;Janine H Santos;Marcelo G Bonini;Ronald P Mason
  • 通讯作者:
    Ronald P Mason
122 - SOD2 Promotes the Metabolic Reprogramming and Sustains the Warburg Effect Via AMPK-Dependent Signaling in Cancer
  • DOI:
    10.1016/j.freeradbiomed.2015.10.163
  • 发表时间:
    2015-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Marcelo G Bonini;Peter C Hart;Mao Mao;Andre L de Abreu;Kristine Ansenberger-Fricano;Dede N Ekoue;Douglas Ganini;Alan M Diamond;Janine H. Santos
  • 通讯作者:
    Janine H. Santos
165 Ablation of NNOS/NOS1 Leads to the Suppression of the Systemic Inflammatory Response via Suppressor of Cytokine Signaling (SOCS-1) Upregulation
  • DOI:
    10.1016/j.freeradbiomed.2012.10.221
  • 发表时间:
    2012-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Saqib Baig;Farnaz Garcia;Kristine Fricano;Jing Deng;Mao Mao;John Christman;Saurabh Chatterjee;Michelle Block;Richard Minshall;Richard Ye;Benjamin Gantner;Marcelo G Bonini
  • 通讯作者:
    Marcelo G Bonini
Free Radical Metabolism by Cytochrome P4502E1 and NADPH Oxidase Activation Forms Protein Radicals and Tyrosine Nitration in ObesityAssociated Nonalcoholic Fatty Liver Disease
  • DOI:
    10.1016/j.freeradbiomed.2010.10.460
  • 发表时间:
    2010-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Saurabh Chatterjee;Douglas Ganini DaSilva;Jinjie Jiang;Marcelo G Bonini;Fabian Leinisch;Maria Kadiiska;Ronald P Mason
  • 通讯作者:
    Ronald P Mason
MnSOD Regulation of AMPK- Mediated Transition toGlycolysis in Breast Cancer
  • DOI:
    10.1016/j.freeradbiomed.2012.10.100
  • 发表时间:
    2012-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Kristine Ansenberger-Fricano;Mao Mao;Paula D. Green;Andrew Hall;Andre Kajdacsy-Balla;Janine A Santos;Marcelo G Bonini
  • 通讯作者:
    Marcelo G Bonini

Marcelo G Bonini的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Marcelo G Bonini', 18)}}的其他基金

Arsenic suppresses progesterone receptor signaling and promotes tamoxifen resistance and metastasis of ER+ breast cancer
砷抑制孕激素受体信号传导并促进 ER 乳腺癌的他莫昔芬耐药性和转移
  • 批准号:
    10662054
  • 财政年份:
    2022
  • 资助金额:
    $ 34.17万
  • 项目类别:
A redox-sensitive switch in the macrophage nucleus regulates acute phase inflammatory injury
巨噬细胞核中的氧化还原敏感开关调节急性期炎症损伤
  • 批准号:
    10451112
  • 财政年份:
    2022
  • 资助金额:
    $ 34.17万
  • 项目类别:
A redox-sensitive switch in the macrophage nucleus regulates acute phase inflammatory injury
巨噬细胞核中的氧化还原敏感开关调节急性期炎症损伤
  • 批准号:
    10631088
  • 财政年份:
    2022
  • 资助金额:
    $ 34.17万
  • 项目类别:
Environmental Arsenic in the Subtype Specification of Breast Cancer
乳腺癌亚型规范中的环境砷
  • 批准号:
    10252934
  • 财政年份:
    2020
  • 资助金额:
    $ 34.17万
  • 项目类别:
Environmental Arsenic in the Subtype Specification of Breast Cancer
乳腺癌亚型规范中的环境砷
  • 批准号:
    10488608
  • 财政年份:
    2020
  • 资助金额:
    $ 34.17万
  • 项目类别:
Environmental Arsenic in the Subtype Specification of Breast Cancer
乳腺癌亚型规范中的环境砷
  • 批准号:
    10204605
  • 财政年份:
    2020
  • 资助金额:
    $ 34.17万
  • 项目类别:
MNSOD ACETYLATION PROMOTES CANCER STEM CELL PHENOTYPES IN BREAST CANCER
MNSOD 乙酰化促进乳腺癌干细胞表型
  • 批准号:
    10221632
  • 财政年份:
    2018
  • 资助金额:
    $ 34.17万
  • 项目类别:
MNSOD ACETYLATION PROMOTES CANCER STEM CELL PHENOTYPES IN BREAST CANCER
MNSOD 乙酰化促进乳腺癌干细胞表型
  • 批准号:
    10193167
  • 财政年份:
    2018
  • 资助金额:
    $ 34.17万
  • 项目类别:
MNSOD ACETYLATION PROMOTES CANCER STEM CELL PHENOTYPES IN BREAST CANCER
MNSOD 乙酰化促进乳腺癌干细胞表型
  • 批准号:
    10380372
  • 财政年份:
    2018
  • 资助金额:
    $ 34.17万
  • 项目类别:
MNSOD ACETYLATION PROMOTES CANCER STEM CELL PHENOTYPES IN BREAST CANCER
MNSOD 乙酰化促进乳腺癌干细胞表型
  • 批准号:
    10453720
  • 财政年份:
    2018
  • 资助金额:
    $ 34.17万
  • 项目类别:

相似海外基金

Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
  • 批准号:
    EP/Y000331/1
  • 财政年份:
    2023
  • 资助金额:
    $ 34.17万
  • 项目类别:
    Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
  • 批准号:
    10677295
  • 财政年份:
    2023
  • 资助金额:
    $ 34.17万
  • 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
  • 批准号:
    10635599
  • 财政年份:
    2023
  • 资助金额:
    $ 34.17万
  • 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
  • 批准号:
    10752320
  • 财政年份:
    2023
  • 资助金额:
    $ 34.17万
  • 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
  • 批准号:
    478927
  • 财政年份:
    2023
  • 资助金额:
    $ 34.17万
  • 项目类别:
    Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
  • 批准号:
    10855703
  • 财政年份:
    2023
  • 资助金额:
    $ 34.17万
  • 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
  • 批准号:
    10654210
  • 财政年份:
    2023
  • 资助金额:
    $ 34.17万
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    $ 34.17万
  • 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
  • 批准号:
    10667952
  • 财政年份:
    2023
  • 资助金额:
    $ 34.17万
  • 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
  • 批准号:
    10726986
  • 财政年份:
    2023
  • 资助金额:
    $ 34.17万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了